Mengis Capital Management, Inc.

Mengis Capital Management, Inc. is a registered investment advisory firm headquartered in Fresno, California. Founded and led by Robert Mengis, who serves as President and Chief Investment Officer, the firm provides discretionary portfolio management and financial planning services to high-net-worth individuals, families, and select retail clients across California's Central Valley and beyond. The firm files with the SEC under CIK #0001609674, and its quarterly 13F disclosures offer a transparent and sustained look into the equity allocation decisions underpinning its client portfolios. Mengis Capital operates as a family-rooted, principal-driven advisory practice. Matthew Mengis serves as Vice President and Portfolio Manager, contributing to the firm's investment process and client-facing operations. This multigenerational leadership structure reflects a long-term institutional orientation — the firm's principals are directly invested alongside clients, creating an alignment of interest that is foundational to the practice's fiduciary mandate. The Fresno base, situated outside of major financial hubs, underscores a culture that favors independent, research-driven decision-making over consensus-following market behavior. The firm's multi-year 13F History is available through this platform, enabling allocators and researchers to trace the trajectory of Mengis Capital's equity positioning across multiple market cycles, sector rotations, and macroeconomic environments.

Mengis Capital Management employs a growth-oriented investment philosophy rooted in fundamental research and a preference for high-quality businesses with demonstrated earnings power, scalable business models, and sustainable competitive positioning. The firm's approach reflects a conviction that long-term wealth creation is best achieved through disciplined ownership of companies whose intrinsic value compounds over time, rather than through market timing or speculative position-taking. Examination of the firm's 13F Portfolio Composition reveals a diversified equity portfolio anchored in large- and mid-capitalization U.S. equities, with notable sector allocations spanning technology, healthcare, financials, and consumer discretionary. The technology weighting reflects a structural preference for companies driving digital transformation and innovation — firms with recurring revenue models, high margins, and network effects that support durable growth runways. Healthcare exposure captures both secular demographic tailwinds and the innovation premium embedded in biotech and medtech leaders. Financial and consumer discretionary holdings provide cyclical balance and valuation diversity within the broader portfolio construct. The firm's security selection process appears to favor companies exhibiting strong returns on equity, robust free cash flow generation, and management teams with disciplined capital allocation track records. This quality filter naturally screens out highly leveraged, speculative, or early-stage businesses in favor of established market participants whose competitive moats and financial resilience support compounding behavior through varied economic conditions. Position management within the Mengis Capital portfolio exhibits low-to-moderate turnover characteristics. Core conviction holdings are maintained across multiple quarters, suggesting a patient, long-duration investment horizon. Incremental adjustments — trimming positions into strength, adding to names during periods of temporary dislocation — are consistent with an active management philosophy that avoids excessive trading while remaining responsive to evolving fundamentals. The firm's Sector Allocation History can be tracked through the platform's analytical tools, providing visibility into how sector tilts have evolved in response to changing market leadership and economic regimes. INVESTMENT RISK PROFILE The risk characteristics of Mengis Capital Management's portfolio are fundamentally shaped by its quality growth orientation and diversified sector construction. By concentrating on financially sound, large-cap equities with proven business models, the firm positions its portfolios to participate meaningfully in equity market appreciation while incorporating structural risk mitigation through business quality rather than explicit hedging mechanisms. The portfolio's diversification across technology, healthcare, financials, and consumer sectors provides natural cross-sector hedging. Technology and healthcare positions, which tend to be driven by secular and innovation-oriented catalysts, may behave differently from financial sector holdings that are more sensitive to interest rate cycles and credit conditions. This multi-factor exposure reduces single-sector concentration risk and creates a more resilient portfolio fabric across varying macroeconomic scenarios. The Max Drawdown Depth associated with Mengis Capital's disclosed holdings can be simulated through the platform's backtesting capabilities. Growth-oriented portfolios with significant technology exposure faced meaningful drawdown pressure during the 2022 rate-driven multiple compression cycle, and analysis of how the firm navigated this period — whether through portfolio repositioning, sector rotation, or conviction-based hold-through — offers valuable insight into its risk management philosophy. Conversely, the same growth tilt would have contributed favorably to capital trajectory during the technology-led recovery phases of 2020–2021 and 2023. The firm's Downside Capture Ratio relative to broad benchmarks such as the S&P 500 is a particularly relevant metric for evaluating Mengis Capital's defensive qualities. Quality growth portfolios that successfully filter for balance sheet strength and cash flow durability often exhibit asymmetric capture characteristics — participating in the majority of upside market movements while capturing a smaller proportion of downside, resulting in superior risk-adjusted outcomes over full market cycles. Platform-based Performance Backtests Online tools enable users to quantify these capture dynamics across customizable time horizons. The low-to-moderate turnover posture introduces a specific risk dimension: in rapidly deteriorating market environments, a patient holding approach means the portfolio may absorb mark-to-market losses during periods when more tactical managers might reduce exposure. However, this tolerance for short-term volatility is consistent with a long-term compounding philosophy that distinguishes between temporary price fluctuation and permanent capital impairment.

Mengis Capital Management, Inc. presents the profile of a disciplined, family-led registered investment advisor with a clearly defined quality growth mandate. Operating from Fresno, California under the leadership of Robert and Matthew Mengis, the firm constructs diversified equity portfolios favoring high-quality, large-cap businesses across technology, healthcare, financials, and consumer sectors. The investment philosophy emphasizes fundamental research, balance sheet quality, and patient capital deployment — hallmarks of an advisory practice built for long-term wealth preservation and compounding rather than short-term performance chasing. The firm's sustained 13F filing history provides a rich dataset for evaluating conviction consistency, sector evolution, and portfolio construction discipline over time. The Annualized Return (CAGR) implied by historical replication of Mengis Capital's disclosed positions can be simulated through the platform's Portfolio Simulator, rescaled to a chosen starting capital, enabling direct benchmarking against relevant indices and peer advisors operating within the quality growth universe. Key distinguishing characteristics — the multigenerational leadership structure, patient turnover profile, quality-focused security selection, and diversified sector allocation — position Mengis Capital as a representative example of the independent, research-driven RIA model that serves as a counterweight to larger, more institutionalized asset management platforms. The firm's Central Valley roots and principal-invested structure suggest a culture of stewardship and long-term client alignment. A critical diagnostic question for researchers and allocators evaluating this firm: Given Mengis Capital's growth-oriented philosophy and meaningful technology sector exposure, how does the portfolio's risk-adjusted capital trajectory perform during sustained periods of rising real interest rates and factor rotation toward deep value — and does the firm's quality filter provide sufficient defensive cushioning to differentiate its compounding behavior from broader growth indices in these adverse regimes?